Literature DB >> 2654625

Genotoxicity of quinoxaline 1,4-dioxide derivatives in Escherichia coli and Salmonella typhimurium.

T Nunoshiba1, H Nishioka.   

Abstract

The mutagenicities of 5 quinoxaline 1,4-dioxide (QdO) derivatives were tested by 2 bacterial assays using forward mutation with Escherichia coli WP2uvrA/pKM101 and reverse mutation with Salmonella typhimurium TA100 and TA98. Potent mutagenic activities of all QdOs tested were observed in both mutation assays. Mutagenicities of these compounds were varied by addition of S9 mix. Their SOS-inducing activities were examined with a 'Rec-lac test' that has been newly developed by us for detecting genotoxins. A high level of SOS-inducing activity was observed in all samples tested. These results suggest that the mutagenicity of QdOs results from the error-prone repair involved in SOS responses.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2654625     DOI: 10.1016/0921-8777(89)90072-4

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  7 in total

1.  c-Myc influences olaquindox-induced apoptosis in human hepatoma G2 cells.

Authors:  Ting Zhang; Shu-Sheng Tang; Xi Jin; Feng-Ying Liu; Chao-Ming Zhang; Wen-Xia Zhao; Shen Zhang; Chun-Di Sun; Xi-Long Xiao
Journal:  Mol Cell Biochem       Date:  2011-05-20       Impact factor: 3.396

2.  Photoprotective effects of some quinoxaline 1,4-dioxides in hairless mice.

Authors:  H U Gali-Muhtasib; M J Haddadin; M Z Nazer; N M Sodir; S W Maalouf
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

3.  Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?

Authors:  Alexander Amberg; Lennart T Anger; Joel Bercu; David Bower; Kevin P Cross; Laura Custer; James S Harvey; Catrin Hasselgren; Masamitsu Honma; Candice Johnson; Robert Jolly; Michelle O Kenyon; Naomi L Kruhlak; Penny Leavitt; Donald P Quigley; Scott Miller; David Snodin; Lidiya Stavitskaya; Andrew Teasdale; Alejandra Trejo-Martin; Angela T White; Joerg Wichard; Glenn J Myatt
Journal:  Mutagenesis       Date:  2019-03-06       Impact factor: 3.000

Review 4.  New small-molecule synthetic antimycobacterials.

Authors:  Lluis Ballell; Robert A Field; Ken Duncan; Robert J Young
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

Review 5.  Bacterial genotoxicity bioreporters.

Authors:  Alva Biran; Sharon Yagur-Kroll; Rami Pedahzur; Sebastian Buchinger; Georg Reifferscheid; Hadar Ben-Yoav; Yosi Shacham-Diamand; Shimshon Belkin
Journal:  Microb Biotechnol       Date:  2009-12-29       Impact factor: 5.813

Review 6.  Quinoxaline 1,4-di-N-Oxides: Biological Activities and Mechanisms of Actions.

Authors:  Guyue Cheng; Wei Sa; Chen Cao; Liangliang Guo; Haihong Hao; Zhenli Liu; Xu Wang; Zonghui Yuan
Journal:  Front Pharmacol       Date:  2016-03-21       Impact factor: 5.810

7.  Synthesis, In-Vitro Activity and Metabolic Properties of Quinocetone and Structurally Similar Compounds.

Authors:  Keyu Zhang; Chunmei Wang; Xiaoyang Wang; Haihong Zheng; Juan Zhao; Mi Wang; Sui Xiao; Chenzhong Fei; Wenli Zheng; Lifang Zhang; Feiqun Xue
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.